- Home
- LENZ vs DHY Comparison
LENZ vs DHY Comparison
Compare LENZ & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | DHY |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.8M | 240.4M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | LENZ | DHY |
|---|---|---|
| Price | $5.57 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 610.6K | 584.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $50.42 | N/A |
| Revenue Next Year | $197.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.73 | $1.72 |
| 52 Week High | $50.19 | $2.16 |
Technical Indicators
Market Signals| Indicator | LENZ | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 26.32 | 46.11 |
| Support Level | N/A | N/A |
| Resistance Level | $10.42 | $2.05 |
| Average True Range (ATR) | 0.43 | 0.02 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 0.56 | 39.13 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.